StonvexLoading…
StonvexStonvexStonvexCore line items from RARE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $136.00M | $673.00M | $465.72M | $305.79M |
Operating Income | $-169.00M | $-535.00M | $-421.72M | $-250.83M |
Net Income | $-185.00M | $-575.00M | $-446.44M | $-266.03M |
EPS (Diluted) | $-1.84 | $-5.83 | $-4.55 | $-2.73 |
Total Assets | $1.30B | $1.53B | $1.19B | $1.31B |
Total Liabilities | $1.52B | $1.60B | $1.17B | $1.15B |
Cash & Equivalents | $175.00M | $421.00M | $202.51M | $176.31M |
Free Cash Flow OCF − CapEx | $-198.00M | $-472.00M | $-371.23M | $-278.53M |
Shares Outstanding | 98.30M | 96.60M | 96.44M | 96.35M |